For more information about gynaecological cancer diagnosis and treatment, see the National Cancer Institute (US)

• Cervical cancer treatment (PDQ®): health professional version,
• Endometrial cancer treatment (PDQ®): health professional version,
• Ovarian epithelial, fallopian tube, and primary peritoneal cancer treatment (PDQ®): health professional version,
• Gestational trophoblastic disease treatment (PDQ®): health professional version,
• Vaginal cancer treatment (PDQ®): health professional version
• Vulvar cancer treatment (PDQ®): health professional version.

Clinical practice guidelines:

• Cancer Australia (2011). Recommendations for the management of women at high risk of ovarian cancer (Note: This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice)
• Cancer Australia (2012). Follow-up of women with epithelial ovarian cancer
• Cancer Australia (2014). Recommendations for the use of first-line chemotherapy for the treatment of women with epithelial ovarian cancer
• Cancer Council Australia (2014). Clinical practice guidelines for the treatment and management of endometrial cancer
• National Comprehensive Cancer Network (2017). NCCN clinical practice guidelines in oncology: cervical cancer, version 1.2017
• National Comprehensive Cancer Network (2017). NCCN clinical practice guidelines in oncology: uterine neoplasms, version 2.2017
• National Comprehensive Cancer Network (2017). NCCN clinical practice guidelines in oncology: ovarian cancer, including fallopian tube cancer and primary peritoneal cancer, version 1.2017
• National Comprehensive Cancer Network (2016). NCCN clinical practice guidelines in oncology: vulvar cancer (squamous cell carcinoma), version 1.2017
• Royal College of Pathologists of Australasia (2013). Cervical cancer structured reporting protocol
• Royal College of Pathologists of Australasia (2013). Vulva cancer structured reporting protocol
• eviQ referral guidelines for ovarian cancer risk assessment and consideration of genetic testing
• eviQ General practitioner referral guidelines for cancer genetics assessment 

When reading materials that are published in other countries, note that some of the information may not apply to Australian patients.

Other resources:

• Cancer Australia (2015): Advice about familial aspects of breast cancer and epithelial ovarian cancer (Note: This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice)
• Cancer Australia (2011): Abnormal vaginal bleeding in pre-, peri and post-menopausal women: a diagnostic guide for general practitioners and gynaecologists (Note: This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice)
• Cancer Australia (2015): Assessment of symptoms that may be ovarian cancer: a guide for GPs
• Cancer Australia (2015): Appropriate referral for women with suspected ovarian cancer
• Cancer Australia (2020): Tools and resources to support the delivery and management of shared follow-up and survivorship care for women with low-risk endometrial cancer
• Cancer Australia (2020): Shared follow-up and survivorship care for women with low-risk endometrial cancer A guide for General Practitioners
• Cancer Australia (2020): Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer